dronabinol has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Ari, Z; Gutman, M; Hochhauser, E; Lahat, E; Pappo, O; Safran, M; Sarne, Y; Shainberg, A; Sultan, M; Waldman, M | 1 |
| Amere, M; Bátkai, S; Battista, N; Gao, RY; Gauson, LA; Horváth, B; Lichtman, AH; Maccarrone, M; Mahadevan, A; Mukhopadhyay, P; Pacher, P; Pertwee, RG; Rajesh, M | 1 |
2 other study(ies) available for dronabinol and Reperfusion Injury
| Article | Year |
|---|---|
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury.
Topics: Animals; Dronabinol; Liver; Male; Mice; Mice, Inbred C57BL; Reperfusion Injury | 2015 |
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
Topics: Alanine Transaminase; Aldehydes; Animals; Apoptosis; Aspartate Aminotransferases; CHO Cells; Cricetinae; Cricetulus; Cytokines; DNA Fragmentation; Dronabinol; Humans; Inflammation; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; Receptor, Cannabinoid, CB2; Reperfusion Injury; RNA, Messenger | 2012 |